Dermata Therapeutics, Inc. (DRMA)
2.08
-0.06
(-2.80%)
USD |
NASDAQ |
Jan 09, 16:00
2.13
+0.05
(+2.40%)
After-Hours: 20:00
Dermata Therapeutics EPS Diluted (Quarterly): -1.648 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 0.2063 |
| Ekso Bionics Holdings, Inc. | -0.5432 |
| Citius Pharmaceuticals, Inc. | -0.4405 |
| Aptevo Therapeutics, Inc. | -40.13 |
| Applied Therapeutics, Inc. | -0.1305 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.692M |
| Total Expenses (Quarterly) | 1.692M |
| Enterprise Value | -2.529M |
| Earnings Yield | -782.1% |
| Normalized Earnings Yield | -782.08 |